Redhill Drug Patent Portfolio
Redhill owns 2 orange book drugs protected by 11 US patents Given below is the list of Redhill's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11878011 | Method for eradicating Helicobacter pylori infection in patients regardless of body mass index | 27 May, 2042 | Active |
| US10238606 | Pharmaceutical compositions for the treatment of Helicobacter pylori | 12 Feb, 2034 | Active |
| US11135172 | Rifabutin-based compositions and methods for treating Helicobacter pylori infection | 12 Feb, 2034 | Active |
| US11931463 | All-in-one fixed-dose combination for treating Helicobacter pylori infection | 12 Feb, 2034 | Active |
| US9050263 | Pharmaceutical compositions for the treatment of Helicobacter pylori | 12 Feb, 2034 | Active |
| US9498445 | Pharmaceutical compositions for the treatment of Helicobacter pylori | 12 Feb, 2034 | Active |
| US9603806 | Pharmaceutical compositions for the treatment of Helicobacter pylori | 12 Feb, 2034 | Active |
| US8263120 | Oral antimicrobial pharmaceutical compositions | 03 May, 2025 | Active |
| US8486446 | Oral antimicrobial pharmaceutical compositions | 03 May, 2025 | Active |
| US8529945 | Oral antimicrobial pharmaceutical compositions | 03 May, 2025 | Active |
| US8741948 | Oral antimicrobial pharmaceutical compositions | 03 May, 2025 | Active |
Latest Legal Activities on Redhill's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Redhill.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 08 May, 2024 | US9498445 |
| Mail Patent eGrant Notification | 19 Mar, 2024 | US11931463 |
|
Recordation of Patent Grant Mailed
Critical
| 19 Mar, 2024 | US11931463 |
| Recordation of Patent eGrant | 19 Mar, 2024 | US11931463 |
| Patent eGrant Notification | 19 Mar, 2024 | US11931463 |
|
Email Notification
Critical
| 19 Mar, 2024 | US11931463 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 19 Mar, 2024 | US11931463 |
|
Email Notification
Critical
| 29 Feb, 2024 | US11931463 |
|
Issue Notification Mailed
Critical
| 28 Feb, 2024 | US11931463 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 13 Feb, 2024 | US8263120 |
| Dispatch to FDC | 09 Feb, 2024 | US11931463 |
|
Application Is Considered Ready for Issue
Critical
| 09 Feb, 2024 | US11931463 |
|
Issue Fee Payment Received
Critical
| 08 Feb, 2024 | US11931463 |
|
Issue Fee Payment Verified
Critical
| 08 Feb, 2024 | US11931463 |
|
Email Notification
Critical
| 23 Jan, 2024 | US11878011 |
Redhill's Family Patents
Redhill Drug List
Given below is the complete list of Redhill's drugs and the patents protecting them.
1. Aemcolo
Aemcolo is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8263120 | Oral antimicrobial pharmaceutical compositions |
03 May, 2025
(6 months from now)
| Active |
| US8486446 | Oral antimicrobial pharmaceutical compositions |
03 May, 2025
(6 months from now)
| Active |
| US8529945 | Oral antimicrobial pharmaceutical compositions |
03 May, 2025
(6 months from now)
| Active |
| US8741948 | Oral antimicrobial pharmaceutical compositions |
03 May, 2025
(6 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Aemcolo's drug page
2. Talicia
Talicia is protected by 7 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11878011 | Method for eradicating Helicobacter pylori infection in patients regardless of body mass index |
27 May, 2042
(17 years from now)
| Active |
| US10238606 | Pharmaceutical compositions for the treatment of Helicobacter pylori |
12 Feb, 2034
(9 years from now)
| Active |
| US11135172 | Rifabutin-based compositions and methods for treating Helicobacter pylori infection |
12 Feb, 2034
(9 years from now)
| Active |
| US11931463 | All-in-one fixed-dose combination for treating Helicobacter pylori infection |
12 Feb, 2034
(9 years from now)
| Active |
| US9050263 | Pharmaceutical compositions for the treatment of Helicobacter pylori |
12 Feb, 2034
(9 years from now)
| Active |
| US9498445 | Pharmaceutical compositions for the treatment of Helicobacter pylori |
12 Feb, 2034
(9 years from now)
| Active |
| US9603806 | Pharmaceutical compositions for the treatment of Helicobacter pylori |
12 Feb, 2034
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Talicia's drug page